Literature DB >> 15256903

Comparison of the efficacy of virus inactivation methods in allogeneic avital bone tissue transplants.

A Pruss1, A Hansen, M Kao, L Gürtler, G Pauli, F Benedix, R Von Versen.   

Abstract

Several procedures for inactivating viruses are used presently in the context of bone tissue transplants. Common methods used are gamma irradiation (25 kGy), treatment with moist heat (82.5 degrees C/15 min., lobator-sd2-system) as well as chemical sterilisation using peracetic acid-ethanol treatment (PES, 2% peracetic acid, 96% ethanol, Aqua [2:1:1], 200 mbar, agitation, 4 hours). Based on national and international guidelines, we tested the antivirucidal effectiveness of these methods in human bone transplants. Three enveloped viruses: human immunodeficiency virus type 2 (HIV-2), pseudorabies virus (PRV), bovine virus diarrhoea virus (BVDV), and three non-enveloped viruses were used: hepatitis A virus (HAV), poliovirus (PV-1), porcine/bovine parvovirus (PPV, BPV). Defatted spongiosa cuboids served as model in chemical treatment experiments, while cortical diaphyses were used in gamma irradiation experiments, and the effects of thermal treatment were tested in prepared femoral heads. The log(10) reduction was measured by cytopathogenic effects after virus titration (TCID(50)/mL). A dose of at least 33.9 kGy (bone model) at -30 +/- 5 degrees C was necessary to achieve a sufficient reduction (4 log(10) steps) of BPV, the most resistant one of all viruses investigated. Thermal treatment as well as PES treatment led to a reduction of virus titres by more than 4 log(10). Only HAV showed a reduction below 4 log(10) (2.87) with PES. After validation of the defatting step included for HAV-infected cells, a HAV-reduction of over 7 log(10) was found. All three sterilisation methods tested are recommended for bone transplant sterilisation, but only provided that additional safety measures (anamnestic informations, infectious serology, PCR in case of multiorgan donors) are taken.

Entities:  

Year:  2001        PMID: 15256903     DOI: 10.1023/A:1021164111246

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  8 in total

1.  Inactivation Effect of Standard and Fractionated Electron Beam Irradiation on Enveloped and Non-Enveloped Viruses in a Tendon Transplant Model.

Authors:  Tanja Schmidt; Arnd T Hoburg; Uwe Gohs; Wolfgang Schumann; Jung-Won Sim-Brandenburg; Andreas Nitsche; Sven Scheffler; Axel Pruss
Journal:  Transfus Med Hemother       Date:  2012-01-20       Impact factor: 3.747

2.  Patient satisfaction and clinical results 10 years after modified open thoracoplasty for pectus deformities.

Authors:  Julia Franziska Funk; Christian Gross; Richard Placzek
Journal:  Langenbecks Arch Surg       Date:  2011-07-16       Impact factor: 3.445

3.  [Modified PemberSal osteotomy technique with lyophilized human allograft].

Authors:  C Druschel; K Heck; C Kraft; R Placzek
Journal:  Oper Orthop Traumatol       Date:  2016-09-14       Impact factor: 1.154

4.  Quantification of growth factors in allogenic bone grafts extracted with three different methods.

Authors:  B Wildemann; A Kadow-Romacker; A Pruss; N P Haas; G Schmidmaier
Journal:  Cell Tissue Bank       Date:  2006-10-25       Impact factor: 1.522

5.  Validation of Serological Testing for Anti-Treponema pallidum from Postmortem Blood on the Siemens-BEP(®)-III Automatic System.

Authors:  Ulrich Kalus; Ina Wilkemeyer; Axel Pruss; Gregor Caspari
Journal:  Transfus Med Hemother       Date:  2013-10-17       Impact factor: 3.747

Review 6.  Allograft Bone as Antibiotic Carrier.

Authors:  Heinz Winkler; Peter Haiden
Journal:  J Bone Jt Infect       Date:  2017-01-01

7.  Silicon nitride: a potent solid-state bioceramic inactivator of ssRNA viruses.

Authors:  Giuseppe Pezzotti; Francesco Boschetto; Eriko Ohgitani; Yuki Fujita; Wenliang Zhu; Elia Marin; Bryan J McEntire; B Sonny Bal; Osam Mazda
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

8.  Endemic impact of human T cell leukemia virus type 1 screening in bone allografts.

Authors:  Yasuhiro Ishidou; Kanehiro Matsuyama; Eiji Matsuura; Takao Setoguchi; Satoshi Nagano; Hironori Kakoi; Masataka Hirotsu; Ichiro Kawamura; Takuya Yamamoto; Setsuro Komiya
Journal:  Cell Tissue Bank       Date:  2016-09-27       Impact factor: 1.522

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.